• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Persistence of SARS-CoV-2 antibodies in kidney transplant recipients.

作者信息

Benotmane Ilies, Gautier Vargas Gabriela, Velay Aurélie, Wendling Marie-José, Perrin Peggy, Fafi-Kremer Samira, Caillard Sophie

机构信息

Department of Nephrology and Transplantation, Strasbourg University Hospital, Strasbourg, France.

INSERM U1109, LabEx TRANSPLANTEX, Strasbourg, France.

出版信息

Am J Transplant. 2021 Jun;21(6):2307-2310. doi: 10.1111/ajt.16469. Epub 2021 Jan 17.

DOI:10.1111/ajt.16469
PMID:33370503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9800460/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f8d/9800460/16329b57a62d/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f8d/9800460/16329b57a62d/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f8d/9800460/16329b57a62d/gr1_lrg.jpg

相似文献

1
Persistence of SARS-CoV-2 antibodies in kidney transplant recipients.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）抗体在肾移植受者中的持续存在情况。
Am J Transplant. 2021 Jun;21(6):2307-2310. doi: 10.1111/ajt.16469. Epub 2021 Jan 17.
2
True effect of monoclonal antibody for COVID-19 in kidney transplant recipients.单克隆抗体对肾移植受者治疗新冠肺炎的真实疗效
Am J Transplant. 2022 May;22(5):1492-1493. doi: 10.1111/ajt.16922. Epub 2021 Dec 18.
3
Immunosuppressive therapy maintenance in a kidney transplant recipient with SARS-CoV-2 pneumonia: A case report.肾移植受者 SARS-CoV-2 肺炎的免疫抑制治疗维持：一例报告。
Am J Transplant. 2020 Jul;20(7):1922-1924. doi: 10.1111/ajt.15920. Epub 2020 May 8.
4
Serological response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients depends on prior exposure to SARS-CoV-2.肾移植受者对新型冠状病毒mRNA疫苗BNT162b2的血清学反应取决于既往对新型冠状病毒的接触情况。
Am J Transplant. 2021 Nov;21(11):3806-3807. doi: 10.1111/ajt.16726. Epub 2021 Jul 10.
5
Serological Response and Clinical Protection of Anti-SARS-CoV-2 Vaccination and the Role of Immunosuppressive Drugs in a Cohort of Kidney Transplant Patients.血清学反应和抗 SARS-CoV-2 疫苗接种的临床保护作用，以及免疫抑制药物在一组肾移植患者中的作用。
Viruses. 2022 Sep 2;14(9):1951. doi: 10.3390/v14091951.
6
Long-term shedding of viable SARS-CoV-2 in kidney transplant recipients with COVID-19.COVID-19 患者肾移植受者中存活的 SARS-CoV-2 的长期脱落。
Am J Transplant. 2021 Aug;21(8):2871-2875. doi: 10.1111/ajt.16636. Epub 2021 Jun 18.
7
Influence of immunosuppression on seroconversion against SARS-CoV-2 in two kidney transplant recipients.免疫抑制对两名肾移植受者抗 SARS-CoV-2 血清转化的影响。
Transpl Infect Dis. 2021 Feb;23(1):e13423. doi: 10.1111/tid.13423. Epub 2020 Aug 8.
8
Severe consequences of COVID-19 infection among vaccinated kidney transplant recipients.接种疫苗的肾移植受者感染新冠病毒的严重后果。
Am J Transplant. 2021 Aug;21(8):2910-2912. doi: 10.1111/ajt.16700. Epub 2021 Jun 14.
9
COVID-19 after two doses of mRNA vaccines in kidney transplant recipients.肾移植受者接种两剂mRNA疫苗后的新冠病毒感染情况。
Am J Transplant. 2021 Dec;21(12):4102-4104. doi: 10.1111/ajt.16778. Epub 2021 Aug 26.
10
COVID-19 infection in solid organ transplant recipients: A single-center experience with patients immediately after transplantation.COVID-19 感染在实体器官移植受者中的情况：移植后即刻患者的单中心经验。
Transpl Infect Dis. 2021 Feb;23(1):e13381. doi: 10.1111/tid.13381. Epub 2020 Jul 6.

引用本文的文献

1
Characterization of the Antibody Response to SARS-CoV-2 Infection in COVID-19 Transplant versus Nontransplant Recipients by Ig-MS.免疫磁珠法分析 COVID-19 移植与非移植受者对 SARS-CoV-2 感染的抗体反应特征。
J Proteome Res. 2024 Sep 6;23(9):3944-3957. doi: 10.1021/acs.jproteome.4c00285. Epub 2024 Aug 15.
2
Evaluation of the Humoral and Cellular Immune Response Post COVID-19 Infection in Kidney Transplant Recipients.肾移植受者感染新冠病毒后体液免疫和细胞免疫反应的评估
J Clin Med. 2023 Jun 7;12(12):3900. doi: 10.3390/jcm12123900.
3
A comparison of antibody response in kidney transplant recipients and healthcare workers who had PCR-confirmed COVID-19 infection.

本文引用的文献

1
SARS-CoV-2 viral dynamics in immunocompromised patients.免疫功能低下患者中的新型冠状病毒2型病毒动力学
Am J Transplant. 2021 Apr;21(4):1667-1669. doi: 10.1111/ajt.16353. Epub 2020 Oct 31.
2
T cell and antibody responses to SARS-CoV-2: Experience from a French transplantation and hemodialysis center during the COVID-19 pandemic.SARS-CoV-2 特异性 T 细胞和抗体应答：COVID-19 大流行期间法国移植和血液透析中心的经验。
Am J Transplant. 2021 Feb;21(2):854-863. doi: 10.1111/ajt.16348. Epub 2020 Nov 6.
3
Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19. Reply.
肾移植受者和经 PCR 确诊感染 COVID-19 的医护人员的抗体反应比较。
Turk J Med Sci. 2022 Dec;52(6):1754-1761. doi: 10.55730/1300-0144.5520. Epub 2022 Dec 21.
4
Assessing T-Cell Immunity in Kidney Transplant Recipients with Absent Antibody Production after a 3rd Dose of the mRNA-1273 Vaccine.评估第三次接种mRNA-1273疫苗后抗体产生缺失的肾移植受者的T细胞免疫。
Int J Mol Sci. 2022 Oct 15;23(20):12333. doi: 10.3390/ijms232012333.
5
Prediction of Vaccine Response and Development of a Personalized Anti-SARS-CoV-2 Vaccination Strategy in Kidney Transplant Recipients: Results from a Large Single-Center Study.肾移植受者中疫苗反应的预测及个性化抗SARS-CoV-2疫苗接种策略的制定：一项大型单中心研究的结果
J Pers Med. 2022 Jul 5;12(7):1107. doi: 10.3390/jpm12071107.
6
COVID-19 and kidney disease: insights from epidemiology to inform clinical practice.新型冠状病毒肺炎与肾脏疾病：从流行病学中获得的见解以指导临床实践
Nat Rev Nephrol. 2022 Aug;18(8):485-498. doi: 10.1038/s41581-022-00570-3. Epub 2022 Apr 13.
7
Longevity of anti-spike and anti-nucleocapsid antibodies after COVID-19 in solid organ transplant recipients compared to immunocompetent controls.COVID-19 后，实体器官移植受者体内的抗刺突蛋白和抗核衣壳抗体与免疫功能正常对照者相比的持久性。
Am J Transplant. 2022 Apr;22(4):1245-1252. doi: 10.1111/ajt.16909. Epub 2021 Dec 14.
8
SARS-CoV-2-specific Humoral and Cellular Immunities in Kidney Transplant Recipients and Dialyzed Patients Recovered From Severe and Nonsevere COVID-19.从重症和非重症新冠肺炎中康复的肾移植受者和透析患者的SARS-CoV-2特异性体液免疫和细胞免疫
Transplant Direct. 2021 Nov 17;7(12):e792. doi: 10.1097/TXD.0000000000001230. eCollection 2021 Dec.
9
Comparing Humoral and Cellular Adaptive Immunity during Convalescent Phase of COVID-19 in Hemodialysis Patients and Kidney Transplant Recipients.比较血液透析患者和肾移植受者新冠康复期的体液和细胞适应性免疫
J Clin Med. 2021 Oct 21;10(21):4833. doi: 10.3390/jcm10214833.
10
COVID-19 in children and young adults with kidney disease: risk factors, clinical features and serological response.儿童和青少年肾脏病患者的 COVID-19：危险因素、临床特征和血清学反应。
J Nephrol. 2022 Jan;35(1):121-129. doi: 10.1007/s40620-021-01171-2. Epub 2021 Oct 15.
轻度新冠肺炎中抗SARS-CoV-2抗体的丧失。回复。
N Engl J Med. 2020 Oct 22;383(17):1697-1698. doi: 10.1056/NEJMc2027051. Epub 2020 Sep 23.
4
Antibody Responses to SARS-CoV-2: Let's Stick to Known Knowns.对 SARS-CoV-2 的抗体反应：让我们坚持已知的事实。
J Immunol. 2020 Nov 1;205(9):2342-2350. doi: 10.4049/jimmunol.2000839. Epub 2020 Sep 4.
5
In-depth virological assessment of kidney transplant recipients with COVID-19.深度评估 COVID-19 肾移植受者的病毒学情况。
Am J Transplant. 2020 Nov;20(11):3162-3172. doi: 10.1111/ajt.16251. Epub 2020 Sep 12.